The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Genomic analysis of fibrolamellar hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sequencing the tumor genomes of FL-HCC patients identified a recurrent chimeric gene6–9 that originates from a ~400 kb deletion in chromosome 19. This deletion causes an in-frame fusion of exon 1 from the DNAJB1 gene, which encodes a member of the heat-shock protein 40 family, with exons 2–10 of the PRKACA gene, encoding for the catalytic subunit of cAMP-dependent protein kinase A (PKA-C)7.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212
Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome
Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232
Research works printed but not linked: 66
- 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
- 2013, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma, Nat. Rev. Cancer, 13, 123, 10.1038/nrc3449 · DOI · Paper page
- 2005, Primary liver carcinoma arising in people younger than 30 years, Am. J. Clin. Pathol., 124, 512, 10.1309/TT0R7KAL32228E99 · doi:10.1309/tt0r7kal32228e99
- 2011, Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors, Semin. Liver Dis., 31, 61, 10.1055/s-0031-1272835 · doi:10.1055/s-0031-1272835
- 2004, Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study, Hepatology, 39, 798, 10.1002/hep.20096 · DOI
- 2005, Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis, Mod. Pathol., 18, 1417, 10.1038/modpathol.3800449 · doi:10.1038/modpathol.3800449
- 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
- 2009, Fibrolamellar hepatocellular carcinoma, Am. J. Gastroenterol., 104, 2617, 10.1038/ajg.2009.440 · DOI
- 2008, EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma, Cancer Res., 68, 1451, 10.1158/0008-5472.CAN-07-6013 · DOI · Paper page
- 2010, Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation, Mod. Pathol., 23, 1180, 10.1038/modpathol.2010.105 · doi:10.1038/modpathol.2010.105
- 2011, Fibrolamellar carcinomas are positive for CD68, Mod. Pathol., 24, 390, 10.1038/modpathol.2010.207 · doi:10.1038/modpathol.2010.207
- 2013, Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers, Hepatology, 57, 1469, 10.1002/hep.26159 · DOI · Paper page
- 1990, Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver, Histopathology, 17, 101, 10.1111/j.1365-2559.1990.tb00679.x · doi:10.1111/j.1365-2559.1990.tb00679.x
- 2007, Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways, Hum. Pathol., 38, 639, 10.1016/j.humpath.2006.07.019 · doi:10.1016/j.humpath.2006.07.019
- 2006, Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma, Hum. Pathol., 37, 410, 10.1016/j.humpath.2005.12.009 · DOI
- 2009, Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene, Hepatology, 49, 821, 10.1002/hep.22695 · DOI · Paper page
- 1997, Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta, Liver, 17, 152, 10.1111/j.1600-0676.1997.tb00798.x · doi:10.1111/j.1600-0676.1997.tb00798.x
- 2010, Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma, Int. J. Clin. Exp. Pathol., 3, 238
- 2012, Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma, PLoS ONE, 7, e30944, 10.1371/journal.pone.0030944 · doi:10.1371/journal.pone.0030944
- 2014, Prognosis of patients with fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis, Gastrointest. Cancer Res., 7, 49
- 1995, Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management, AJR Am. J. Roentgenol., 164, 1153, 10.2214/ajr.164.5.7717223 · doi:10.2214/ajr.164.5.7717223
- 2003, Fibrolamellar hepatocellular carcinoma in children and adolescents, Cancer, 97, 2006, 10.1002/cncr.11292 · DOI
- 2013, Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium, Gastrointest. Cancer Res., 6, 3
- 2013, Fibrolamellar variant of hepatocellular carcinoma, Recent Results Cancer Res., 190, 101, 10.1007/978-3-642-16037-0_7 · doi:10.1007/978-3-642-16037-0_7
- 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- 2009, Anterior gradient-2 is overexpressed by fibrolamellar carcinomas, Hum. Pathol., 40, 293, 10.1016/j.humpath.2008.08.003 · doi:10.1016/j.humpath.2008.08.003
- 1984, Neurotensin secretion by fibrolamellar carcinoma of the liver, Lancet, 1, 538
- 1991, ‘Neuroendocrine’ differentiation in primary neoplasms of the liver, J. Pathol., 163, 61, 10.1002/path.1711630111 · doi:10.1002/path.1711630111
- 2014, Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature, Hepatology, 59, 2228, 10.1002/hep.27018 · DOI
- 1993, Infrequent chromosome allele loss in fibrolamellar carcinoma, Br. J. Cancer, 67, 244, 10.1038/bjc.1993.47 · doi:10.1038/bjc.1993.47
- 2012, Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nat. Genet., 44, 694, 10.1038/ng.2256 · DOI · Paper page
- 2012, Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators, Nat. Genet., 44, 760, 10.1038/ng.2291 · DOI · Paper page
- 2012, Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma, Nat. Genet., 44, 1117, 10.1038/ng.2391 · DOI · Paper page
- 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 · DOI · Paper page
- 2000, Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients, Oncogene, 19, 3733, 10.1038/sj.onc.1203713 · doi:10.1038/sj.onc.1203713
- 2000, Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization, Am. J. Clin. Pathol., 114, 867, 10.1309/BMTT-JBPD-D13H-1UVD · doi:10.1309/bmtt-jbpd-d13h-1uvd
- 1992, Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells, Cell Struct. Funct., 17, 77, 10.1247/csf.17.77 · DOI
- 2006, Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells, Nature, 439, 349, 10.1038/nature04410 · DOI · Paper page
- 2009, Sequence variants at the TERT-CLPTM1L locus associate with many cancer types, Nat. Genet., 41, 221, 10.1038/ng.296 · DOI · Paper page
- 2006, Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism, Nat. Genet., 38, 682, 10.1038/ng1802 · DOI · Paper page
- 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943 · DOI · Paper page
- 2014, The prenatal origins of cancer, Nat. Rev. Cancer, 14, 277, 10.1038/nrc3679 · DOI · Paper page
- 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, 481, 329, 10.1038/nature10733 · DOI · Paper page
- 1992, Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762), Blood, 80, 2983, 10.1182/blood.V80.12.2983.2983 · DOI · Paper page
- 1993, Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations, N. Engl. J. Med., 329, 909, 10.1056/NEJM199309233291302 · DOI · Paper page
- 1994, Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma, Cancer Res., 54, 2869
- 1994, A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG, Nat. Genet., 6, 146, 10.1038/ng0294-146 · DOI · Paper page
- 1995, Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia, Proc. Natl. Acad. Sci. USA, 92, 4917, 10.1073/pnas.92.11.4917 · DOI · Paper page
- 1996, In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma, Hum. Mol. Genet., 5, 15, 10.1093/hmg/5.1.15 · DOI
- 1998, ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma, Cancer Res., 58, 5046
- 1998, NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia, Cancer Res., 58, 4269
- 1999, The role of TEL fusion genes in pediatric leukemias, Leukemia, 13, 6, 10.1038/sj.leu.2401258 · DOI
- 2003, A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23), Oncogene, 22, 5374, 10.1038/sj.onc.1206686 · DOI · Paper page
- 2014, Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR, Nat. Genet., 46, 39, 10.1038/ng.2849 · DOI · Paper page
- 1984, Chromosome rearrangements in oncogenesis, Microbiol. Sci., 1, 223
- 2010, Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions, Eur. J. Hum. Genet., 18, 1302, 10.1038/ejhg.2010.115 · DOI
- 2013, A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors, Cancer Discov., 3, 1364, 10.1158/2159-8290.CD-13-0183 · DOI · Paper page
- 2007, Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells, Cancer Res., 67, 3663, 10.1158/0008-5472.CAN-06-2616 · DOI
- 2013, p21-Activated kinase 4 promotes prostate cancer progression through CREB, Oncogene, 32, 2475, 10.1038/onc.2012.255 · DOI
- 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat. Genet., 46, 613, 10.1038/ng.2956 · DOI · Paper page
- 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
- 2009, Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization, Mod. Pathol., 22, 134, 10.1038/modpathol.2008.178 · doi:10.1038/modpathol.2008.178
- 2010, Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver, PLoS ONE, 5, e13688, 10.1371/journal.pone.0013688 · DOI
- 2010, Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas, Mod. Pathol., 23, 790, 10.1038/modpathol.2010.51 · DOI
- 2011, A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer, Nat. Genet., 43, 1210, 10.1038/ng.985 · DOI · Paper page
- 2008, Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family, Cell Stem Cell, 3, 416, 10.1016/j.stem.2008.07.009 · DOI · Paper page
Cited by
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Metadata
- Authors
- Xu, L., Hazard, F. K., Zmoos, A.-F., Jahchan, N., Chaib, H., Garfin, P. M., Rangaswami, A., Snyder, M. P., & Sage, J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-13
- Volume
- 24
- Issue
- 1
- Pages
- 50-63
- ISSN
- 0964-6906
- 1460-2083
- Cited by
- 72
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genomic analysis of fibrolamellar hepatocellular carcinoma. https://app.cochat.ai/papers/10.1093/hmg/ddu418
- The paper
- Xu, L., Hazard, F. K., Zmoos, A.-F., Jahchan, N., Chaib, H., Garfin, P. M., Rangaswami, A., Snyder, M. P., & Sage, J. (2015). Genomic analysis of fibrolamellar hepatocellular carcinoma. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddu418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.